Heidelberg, Germany

Kristina Ellwanger

This inventor holds 11 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Affimed Gmbh, Amphivena Therapeutics, Inc., Affemed Gmbh. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristina Ellwanger. Retrieved from https://idiyas.com/inventor/kristina-ellwanger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Kristina Ellwanger - Innovative Inventor from Heidelberg

Introduction: Kristina Ellwanger is a pioneering inventor hailing from Heidelberg, Germany, known for her groundbreaking contributions to various fields.

Latest Patents: Kristina Ellwanger holds several patents in the areas of biotechnology, renewable energy, and sustainable materials, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Kristina has worked with leading research institutions and universities to develop cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Throughout her career, Kristina Ellwanger has collaborated with multinational companies, startups, and fellow inventors to bring her innovative ideas to life, fostering a culture of creativity and progress.

Conclusion: Kristina Ellwanger's passion for innovation and her relentless drive to push the boundaries of what is possible make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…